phenobarbital has been researched along with Atresia, Biliary in 8 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to re-evaluate the accuracy of phenobarbital-enhanced hepatobiliary scintigraphy in differentiating biliary atresia from other causes of neonatal cholestasis." | 7.79 | Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. ( Ghelani, S; Kwatra, N; Majd, M; Mohan, P; Narayanan, S; Shalaby-Rana, E, 2013) |
| " Group 1 (n = 48), group 2 (n = 29), and group 3 (n = 18) received phenobarbital at the dosage of 5 mg/kg/day for at least 5 days, less than 5 mg/kg/day or less than 5 days, and no premedication, respectively." | 5.32 | The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome. ( Charearnrad, P; Chongsrisawat, V; Poovorawan, Y; Tepmongkol, S, 2003) |
| "The purpose of this study was to re-evaluate the accuracy of phenobarbital-enhanced hepatobiliary scintigraphy in differentiating biliary atresia from other causes of neonatal cholestasis." | 3.79 | Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. ( Ghelani, S; Kwatra, N; Majd, M; Mohan, P; Narayanan, S; Shalaby-Rana, E, 2013) |
| "Phenobarbital is a long-acting barbiturate metabolized in the liver by the cytochrome p450 3a4 system." | 1.33 | Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient. ( Bristow, LJ; Chang, IF; Goss, JA; Karpen, SJ; Quirós-Tejeira, RE, 2005) |
| " Group 1 (n = 48), group 2 (n = 29), and group 3 (n = 18) received phenobarbital at the dosage of 5 mg/kg/day for at least 5 days, less than 5 mg/kg/day or less than 5 days, and no premedication, respectively." | 1.32 | The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome. ( Charearnrad, P; Chongsrisawat, V; Poovorawan, Y; Tepmongkol, S, 2003) |
| "Phenobarbital was administered to 22 patients before imaging." | 1.29 | Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice. ( Ben-Haim, S; Brown, BP; Johnson, J; Kao, SC; Seabold, JE; Tran, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwatra, N | 1 |
| Shalaby-Rana, E | 1 |
| Narayanan, S | 1 |
| Mohan, P | 1 |
| Ghelani, S | 1 |
| Majd, M | 1 |
| Charearnrad, P | 1 |
| Chongsrisawat, V | 1 |
| Tepmongkol, S | 1 |
| Poovorawan, Y | 1 |
| Quirós-Tejeira, RE | 1 |
| Chang, IF | 1 |
| Bristow, LJ | 1 |
| Karpen, SJ | 1 |
| Goss, JA | 1 |
| Sevilla, A | 1 |
| Howman-Giles, R | 1 |
| Saleh, H | 1 |
| Trpezanovski, J | 1 |
| Concannon, R | 1 |
| Williams, K | 1 |
| Chung, D | 1 |
| Uren, R | 1 |
| Ben-Haim, S | 1 |
| Seabold, JE | 1 |
| Kao, SC | 1 |
| Johnson, J | 1 |
| Tran, D | 1 |
| Brown, BP | 1 |
| Lin, WY | 1 |
| Lin, CC | 1 |
| Changlai, SP | 1 |
| Shen, YY | 1 |
| Wang, SJ | 1 |
| Golladay, ES | 1 |
| Slezak, JW | 1 |
| Seibert, JJ | 1 |
| Rivera-Echegoyen, M | 1 |
| Ramírez-Mayans, JA | 1 |
| Casaubón-Garcín, P | 1 |
| Núñez-Malaver, CE | 1 |
| Avila-Ramírez, E | 1 |
| Sosa-Martínez, C | 1 |
8 other studies available for phenobarbital and Atresia, Biliary
| Article | Year |
|---|---|
Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center.
Topics: Biliary Atresia; Causality; Cholestasis; District of Columbia; Female; Humans; Image Enhancement; In | 2013 |
The effect of phenobarbital on the accuracy of technetium-99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome.
Topics: Biliary Atresia; Excitatory Amino Acid Antagonists; Female; Hepatitis; Humans; Infant; Infant, Newbo | 2003 |
Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
Topics: Biliary Atresia; Half-Life; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; P | 2005 |
Hepatobiliary scintigraphy with SPECT in infancy.
Topics: Biliary Atresia; Female; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Phenobarbital; Retro | 2007 |
Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice.
Topics: Aniline Compounds; Biliary Atresia; Cholestasis, Intrahepatic; Female; Glycine; Hepatitis; Humans; I | 1995 |
Comparison technetium of Tc-99m disofenin cholescintigraphy with ultrasonography in the differentiation of biliary atresia from other forms of neonatal jaundice.
Topics: Biliary Atresia; Cholestyramine Resin; Diagnosis, Differential; Female; Humans; Imino Acids; Infant; | 1997 |
Intractable cholangitis due to conduit obstruction.
Topics: Anti-Bacterial Agents; Biliary Atresia; Child; Cholangitis; Clinical Protocols; Humans; Methylpredni | 1990 |
[Neonatal cholestatic syndrome: use of phenobarbital in the gammagram of the bile ducts].
Topics: Bile Ducts; Biliary Atresia; Bilirubin; Diagnosis, Differential; Female; Humans; Imino Acids; Infant | 1988 |